CLASS II Drug recall · Reported 25 Jun 2014 · FDA Enforcement Report

Testosterone Cypionate for Injection recalled by John W Hollis

John W Hollis is recalling Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate 200 mg, distributed nationwide in the US. The recall was initiated on 12 May 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codeslot# 1157, Use by 09/16/14; lot# 2357, use by 06/01/14
Quantity recalled50 mL

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1392-2014
FDA event ID
68557
Recalling firm
John W Hollis, Nashville, TN
Classification
Class II
Status
Terminated
Recall initiated
12 May 2014
FDA classified
18 Jun 2014
Reported
25 Jun 2014
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Sterility

Timeline

12 May 2014Recall initiated by company
18 Jun 2014Classified by FDA+37 days
25 Jun 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate 200 mg, also contains: Cotton Seed Oil, Benzyl Benzoate, Benzyl Alcohol, Rx Only, 10 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate 200 mg recalled?

Yes. John W Hollis recalled Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate 200 mg on 12 May 2014. The recall is Class II and its status is Terminated. Recall number D-1392-2014.

Why was it recalled?

Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.

Which lots are affected?

lot# 1157, Use by 09/16/14; lot# 2357, use by 06/01/14

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from John W Hollis

All 23

Other Testosterone cypionate recalls

All 23